Literature DB >> 29730418

Effects of pregabalin on brain edema, neurologic and histologic outcomes in experimental traumatic brain injury.

Manzumeh Shamsi Meymandi1, Zahra Soltani2, Gholamreza Sepehri3, Sedigheh Amiresmaili4, Fatemeh Farahani5, Mohammadmehdi Moeini Aghtaei6.   

Abstract

Brain edema and increased intracranial pressure (ICP) are among the main causes of neurological disturbance and mortality following traumatic brain injury (TBI). Since pregabalin neuroprotective effects have been shown, this study was performed to evaluate the possible neuroprotective effects of pregabalin in experimental TBI of male rats. Adult male Wistar rats were divided into 4 groups: sham, vehicle, pregabalin 30 mg/kg and pregabalin 60 mg/kg. TBI was induced in vehicle and pregabalin groups by Marmarou method. Pregabalin was administered 30 min after TBI. Sham and vehicle groups received saline. Brain water and Evans blue content and histopathological changes were evaluated 24, 5 and 24 h after TBI, respectively. The ICP and neurological outcomes (veterinary coma scale, VCS) were recorded before, 1 h and 24 h post TBI. The results showed a significant reduction in brain water content and ICP, and a significant increase in VCS of pregabalin group (60 mg/kg) as compared to vehicle group (P < 0.05). Also, pregabalin reduced brain edema and apoptosis score as compared to vehicle group. Post TBI pregabalin administration revealed a delayed but significant improvement in ICP and neurological outcomes in experimental TBI. The underlying mechanism(s) was not determined and needs further investigation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain edema; Intracranial pressure; Neurological outcome; Pregabalin; Traumatic brain injury

Mesh:

Substances:

Year:  2018        PMID: 29730418     DOI: 10.1016/j.brainresbull.2018.05.001

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  10 in total

Review 1.  Pathophysiology and treatment of cerebral edema in traumatic brain injury.

Authors:  Ruchira M Jha; Patrick M Kochanek; J Marc Simard
Journal:  Neuropharmacology       Date:  2018-08-04       Impact factor: 5.250

Review 2.  Can Mesenchymal Stem Cells Act Multipotential in Traumatic Brain Injury?

Authors:  Fatemeh Dehghanian; Zahra Soltani; Mohammad Khaksari
Journal:  J Mol Neurosci       Date:  2020-01-02       Impact factor: 3.444

3.  Protective effect of pregabalin on the brain tissue of diabetic rats.

Authors:  Caner F Demir; Metin Balduz; İrem Taşcı; Tuncay Kuloğlu
Journal:  Diabetol Int       Date:  2020-11-16

4.  Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats.

Authors:  Xiang Yao; Wenping Yang; Zhendong Ren; Haoran Zhang; Dafa Shi; Yanfei Li; Ziyang Yu; Qiu Guo; Guangwei Yang; Yingjiang Gu; Hairong Zhao; Ke Ren
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

5.  The Effect of Candesartan Alone and Its Combination With Estrogen on Post-traumatic Brain Injury Outcomes in Female Rats.

Authors:  Mojdeh Hajmohammadi; Mohammad Khaksari; Zahra Soltani; Nader Shahrokhi; Hamid Najafipour; Reza Abbasi
Journal:  Front Neurosci       Date:  2019-12-03       Impact factor: 4.677

6.  Mitochondrial-Protective Effects of R-Phenibut after Experimental Traumatic Brain Injury.

Authors:  Einars Kupats; Gundega Stelfa; Baiba Zvejniece; Solveiga Grinberga; Edijs Vavers; Marina Makrecka-Kuka; Baiba Svalbe; Liga Zvejniece; Maija Dambrova
Journal:  Oxid Med Cell Longev       Date:  2020-11-21       Impact factor: 6.543

7.  The Effect of Oral Mucosal Mesenchymal Stem Cells on Pathological and Long-Term Outcomes in Experimental Traumatic Brain Injury.

Authors:  Fatemeh Dehghanian; Zahra Soltani; Alireza Farsinejad; Mohammad Khaksari; Elham Jafari; Ali Darakhshani; Nazanin Sabet; Hamideh Bashiri
Journal:  Biomed Res Int       Date:  2022-04-26       Impact factor: 3.246

8.  Pregabalin mitigates microglial activation and neuronal injury by inhibiting HMGB1 signaling pathway in radiation-induced brain injury.

Authors:  Zhan Zhang; Jingru Jiang; Yong He; Jinhua Cai; Jiatian Xie; Minyi Wu; Mengdan Xing; Zhenzhen Zhang; Haocai Chang; Pei Yu; Siqi Chen; Yuhua Yang; Zhongshan Shi; Qiang Liu; Haohui Sun; Baixuan He; Junbo Zeng; Jialin Huang; Jiongxue Chen; Honghong Li; Yi Li; Wei-Jye Lin; Yamei Tang
Journal:  J Neuroinflammation       Date:  2022-09-21       Impact factor: 9.587

9.  JM-20 Treatment After Mild Traumatic Brain Injury Reduces Glial Cell Pro-inflammatory Signaling and Behavioral and Cognitive Deficits by Increasing Neurotrophin Expression.

Authors:  Andrezza Bond Vieira Furtado; Debora Farina Gonçalves; Diane Duarte Hartmann; Aline Alves Courtes; Gustavo Cassol; Yanier Nunez-Figueredo; Deivison Silva Argolo; Ravena Pereira do Nascimento; Silvia Lima Costa; Victor Diogenes Amaral da Silva; Luiz Fernando Freire Royes; Félix Alexandre Antunes Soares
Journal:  Mol Neurobiol       Date:  2021-06-19       Impact factor: 5.590

10.  Role of cyclin-dependent kinase 5 in early brain injury following experimental subarachnoid hemorrhage.

Authors:  Yu Ding; Liexiang Zhang; Wei Zhou; Hai Lu; Xingde Gao; Jian Li; Jingde Liu; Xiaowang Niu; Jing Zheng
Journal:  Exp Ther Med       Date:  2021-12-15       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.